**Challani Capital Limited** (formerly known as **Indo Asia Finance Limited**) is a Chennai-based **Non-Banking Finance Company (NBFC)** registered with the **Reserve Bank of India (RBI No. 07-00308)**. Classified as a **Category B Non-Deposit Accepting Loan Company**, the firm specializes in providing credit solutions to small business owners and middle-class households. Under the leadership of the **Challani Group**, the company is currently undergoing a strategic transformation, integrating traditional lending with advanced health-tech interventions and a modernized corporate identity. --- ### **Core Credit Portfolio & Specialized Lending Services** The company operates a focused credit engine targeting retail and corporate segments through a mix of secured and working capital products. * **Secured Loan against Property (LAP):** The cornerstone of the company’s business engagement, providing long-term credit backed by real estate collateral. * **Gold Loans:** Immediate liquidity solutions secured against gold ornaments, catering to the urgent capital needs of the middle-class demographic. * **Commercial Vehicle (CV) Loans:** Financing for transport and commercial use, supporting small-scale logistics entrepreneurs. * **Sales and Purchase Factoring:** Specialized working capital solutions through receivable financing to support the cash flow cycles of small businesses. * **Historical Offerings:** The company maintains a legacy of providing unsecured business/personal loans and housing finance, though current focus has shifted toward secured asset classes. --- ### **Strategic Pivot: Health Technology & Digital Therapeutics** A unique differentiator for Challani Capital is its expansion into advanced health technology, specifically targeting the chronic disease management market through its **Whole Body Digital Twin™** technology. * **Twin Precision Treatment:** An AI-driven platform that creates a multidimensional digital representation of an individual’s metabolism to address the root causes of chronic diseases. * **Type 2 Diabetes Reversal:** The primary therapeutic focus is achieving **medication-free recovery** for diabetic patients. * **Clinical Validation:** In a **Randomized Control Trial (RCT)** conducted with the **IIT Madras Research Park (IITMRP)** involving **206 intervention patients**, **over 90%** achieved significant health improvements or recovery milestones. * **Digital Safety Ecosystem:** To support its digital health delivery, the company has integrated safety tools including **Block and Report** functions and **Forward Labels**. It also collaborates with **Fact-Checking Organizations** to combat misinformation. --- ### **Financial Performance & Capital Structure** The company has demonstrated a significant trajectory of growth in income and profitability, maintaining a high-margin operational model. **Key Financial Metrics (Year-on-Year Comparison):** | Metric | FY 2024-25 | FY 2023-24 | | :--- | :--- | :--- | | **Total Income** | **₹ 2.74 crore** | **₹ 1.19 crore** | | **Net Profit After Tax (PAT)** | **₹ 1.86 crore** | **₹ 50.66 Lakhs** | | **Cash & Cash Equivalents** | **₹ 91.68 Lakhs** | **₹ 6.15 Lakhs** | | **Operating Profit Margin** | **74.29%** | **44.73%** | | **Net Profit Margin** | **74.14%** | **42.45%** | **Capital and Reserves:** * **Authorized Share Capital:** **₹ 15,51,00,000** (divided into **1,55,10,000 Equity Shares** of **₹ 10** each). * **Dividend Policy:** The Board has **not recommended a dividend** for the period ended **31.03.2025**, opting to retain earnings for business expansion. * **Debt Profile:** The company maintains a conservative leverage profile with a **Debt-Equity Ratio of 0.18** (as of 2025). --- ### **Corporate Rebranding & Governance Framework** In late 2023, the company executed a major rebranding to align with the "Challani" brand identity following **RBI** approval. | Previous Name | New Name | Effective Date | | :--- | :--- | :--- | | **Indo Asia Finance Limited** | **Challani Capital Limited** | **Nov/Dec 2023** | **Leadership and Management:** * **Managing Director:** **Mr. Padam J Challani** has been re-appointed for a **3-year term** (April 2025 – March 2028). Notably, he has volunteered to serve **without monetary remuneration**. Due to his age (**70+ years**), this appointment is subject to a **Special Resolution**. * **Statutory Oversight:** **M/s. RSM & Associates** was appointed as the **Statutory Auditor** in **December 2023**. * **Related Party Transactions (RPT):** The company has established a five-year framework (FY 2024-25 to FY 2028-29) with an expenditure limit of **₹ 60 Crores per financial year** to facilitate operational flexibility. --- ### **Risk Management & Regulatory Compliance** The company operates within a rigorous risk assessment framework monitored by the **Assets Liability Management Committee (ALCO)**. * **Credit & Liquidity Risk:** Monitored via **EMI default rates**, **collection efficiency**, and a **three-stage asset classification** framework. The company tracks the "gap" between long-term assets and funding sources. * **Market & Interest Rate Risk:** The company utilizes **Value at Risk (VaR)**, **modified duration analysis**, and **simulated stress tests** to manage sensitivity to market fluctuations. * **Regulatory Challenges:** * The company is currently disputing a **₹ 4,05,920 penalty** from the **BSE** regarding the delayed submission of the FY 2022-23 Annual Report. * **Shareholding Rectification:** A minor **0.24%** of promoter holdings remain in physical form. An inter-se transfer error within the promoter group (mistaken for a pledge) is currently undergoing rectification with the depository. * **Compliance History:** Management has addressed historical lapses, including a previous **20-month CFO vacancy** and incomplete **Structured Digital Database (SDD)** updates for insider trading regulations. --- ### **Operational Infrastructure & Lease Obligations** Challani Capital operates primarily from its headquarters in **Chennai**, utilizing a localized marketing strategy rather than high-cost national campaigns. **Lease Commitments:** The company operates from leased premises with non-cancellable agreements (36–60 months). | Particulars (Minimum Lease Obligations) | 31/03/2025 (₹) | 31/03/2024 (₹) | | :--- | :--- | :--- | | Not later than one year | **10,250** | **22,500** | | Later than one year but not later than five years | **-** | **-** | **Internal Controls:** The company maintains internal control systems tailored to its size, focusing on the **sale of services** and fixed asset management. As a pure-play finance and tech-service entity, the business model does not involve inventory or the sale of physical goods.